CCOLA Fair Value & Analysis
Consumer Defensive · Market cap 246B TRY
Fair value as of: Aug 6, 2026
From 24 valuation models · updated today
Share price +6.7% over the past month.
A solid business, screening 20% undervalued on our models.
What matters now
- Solid quality (58/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (69.33 TRY to 132.02 TRY) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 6, 2026.
How to read this chart
60‑month range 6.26 TRY – 92.35 TRY · fair‑value band 69.33 TRY – 132.02 TRY · the 87.95 TRY price screens below the 105.62 TRY fair value. Dashed = 300-day average. As of Aug 6, 2026.
Analysis
CCOLA (CCOLA) currently trades at 87.95 TRY, while our model-based Fair Value estimate is 105.62 TRY, implying the stock looks roughly 20.1% undervalued today. We read business quality at 58/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, CCOLA generated revenue of 192B TRY at a net margin of 9.2%. Revenue grew 10.7% year over year. It earns a return on equity of 22.0%. Net debt stands at 24.4B TRY. Fundamentals as of Aug 6, 2026
Our scenario range runs from 69.33 TRY (bear case) to 132.02 TRY (bull case); at 87.95 TRY, the current price sits within that range. The share trades about 6% below its 52-week high and 98% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -14% fair-value upside, at 20%, CCOLA screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings (210.77 TRY) versus Asset-Based (18.16 TRY). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 6, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 47 · Market factors (momentum, volatility) 80
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
CCOLA reported revenue of 187B TRY in FY2025 versus 21.9B TRY in FY2021, a compound +70.9%/yr. Reported net income was 14.1B TRY in FY2025, compounding +57.8%/yr from FY2021.
Watch CCOLA: get an alert when its fair value changes →
Peer Group
Beverages - Non-Alcoholic · 90 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Beverages - Non-Alcoholic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Beverages - Non-Alcoholic stocks, each showing price versus our Fair Value estimate (as of Aug 6, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Coca-Cola Company KO | $81.56 | $39.92 | -51% |
| PepsiCo, Inc PEP | $137.38 | $106.91 | -22% |
| Monster Beverage Corporation MNST | $97.50 | $35.82 | -63% |
| Nongfu Spring Co 9633 | HK$41.44 | HK$30.72 | -26% |
| Coca-Cola Europacific Partners PLC CCEP | €92.10 | €85.41 | -7% |
| Keurig Dr Pepper Inc KDP | $31.25 | $30.99 | -1% |
| Coca-Cola FEMSA, S.A. KOF | $102.04 | $106.45 | +4% |
| Coca-Cola HBC AG EEE | €57.90 | €52.82 | -9% |
| Varun Beverages Limited VBL | ₹495.70 | ₹187.49 | -62% |
| Eastroc Beverage (Group) Co 605499 | ¥124.43 | ¥107.57 | -14% |
Compare CCOLA with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is CCOLA overvalued or undervalued?
What is the fair value of CCOLA?
What is the quality score of CCOLA?
What is the revenue of CCOLA?
What is the net profit margin of CCOLA?
Does CCOLA pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track CCOLA and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.